Globally, development of efficient and advanced technology, rise in
awareness among people, increasing government initiatives across the
globe, growing healthcare expenditure, and growing development and
commercialization of pipeline drugs are the prime growth drivers of
global Musculoskeletal Diseases market. In addition, increase in
adoption of Musculoskeletal Diseases drugs in emerging economies such as
China, India and others, will create new opportunities for global
Musculoskeletal Diseases market. However, higher cost of the research
and development, complex government approval process and risk of side
effects are the key restraints for global Musculoskeletal Diseases
market.

Geographically, Americas dominated the global Musculoskeletal Diseases
market, because of over-use of weak muscles, tendons, or ligaments,
vigorous vocational activities. Asia Pacific is projected to have
fastest growth, owing to prevalence of conditions such as
osteoarthritis, rheumatoid arthritis, and degenerative disc diseases
increase in developing nations such as China, and India in this region.
Among all the treatments, biologics procedures has the highest market
share in global Musculoskeletal Diseases market due to higher prevalence
of cancer patients.

This report identifies the global Musculoskeletal Diseases market size
in for the year 2014-2016, and forecast of the same for year 2021. It
also highlights the market drivers, restraints, growth indicators,
challenges, and other key aspects with respect to global Musculoskeletal
Diseases market.

ResearchAndMarkets.com is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.